Cite
HARVARD Citation
French, P. et al. (n.d.). P01.066 Patients with EGFR amplification but without EGFRvIII expression have improved benefit compared to those with EGFRvIII expression in samples of the INTELLANCE 2/EORTC 1410 randomized phase II trial. Neuro-oncology. pp. iii244-iii245. [Online].